A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder

Autor: Parmenter, Megan E., Lederman, Seth, Weathers, Frank W., Davis, Lori L., Vaughn, Benjamin, Engels, Jean, Sullivan, Gregory M.
Zdroj: In Psychiatry Research April 2024 334
Databáze: ScienceDirect
Externí odkaz: